Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
European Journal of Clinical Microbiology & Infectious Diseases
Published in: European Journal of Clinical Microbiology & Infectious Diseases 5/2008

01-05-2008 | Article

Predicting mortality in patients with systemic inflammatory response syndrome: an evaluation of two prognostic models, two soluble receptors, and a macrophage migration inhibitory factor

Authors: K. Kofoed, J. Eugen-Olsen, J. Petersen, K. Larsen, O. Andersen

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 5/2008

Login to get access

Abstract

Better outcomes in patients suspected of community-acquired infections requires the optimal and timely assessment of disease severity at the point of first contact with the health care system, which is typically in the emergency department. This study was conducted using a previously described, prospectively collected cohort of patients with systemic inflammatory response syndrome (SIRS) that were admitted to an emergency department and a department of infectious diseases at a university hospital. Plasma samples were collected and disease severity scores calculated upon admission. A multiplex immunoassay and a newly developed enzyme-linked immunosorbent assay (ELISA)-based assay were used to measure the soluble urokinase-type plasminogen activator receptor, soluble triggering receptor expressed on myeloid cells-1, and macrophage migration inhibitory factor. The area under the receiver operating characteristic (ROC) curve for the prediction of 30- and 180-day mortality was used to compare the performance of the markers and the models. A total of 151 patients were eligible for analysis. Of these, nine died before day 30 and 19 died before day 180 post-admission. Admission-soluble urokinase-type plasminogen activator receptor levels were significantly higher in both day 30 and day 180 non-survivors. There was a non-significant trend towards higher macrophage migration inhibitory factor concentrations in day 30 non-survivors. Soluble triggering receptor expressed on myeloid cells-1 levels were significantly lower in non-survivors at both time points. The simplified acute physiology score II (SAPS II) and sequential organ failure assessment (SOFA) scores were significantly higher in non-survivors at both time points, indicating that these models intended for use in intensive care units might also be useful in an emergency department setting.
Literature
1.
Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644–1655PubMedCrossRef
2.
Huang DT (2004) Clinical review: impact of emergency department care on intensive care unit costs. Crit Care 8:498–502PubMedCrossRef
3.
Rivers EP, Nguyen HB, Amponsah D (2003) Sepsis: a landscape from the emergency department to the intensive care unit. Crit Care Med 31:968–969PubMedCrossRef
4.
Sands KE, Bates DW, Lanken PN, Graman PS, Hibberd PL, Kahn KL, Parsonnet J, Panzer R, Orav EJ, Snydman DR, Black E, Schwartz JS, Moore R, Johnson BL Jr, Platt R (1997) Epidemiology of sepsis syndrome in 8 academic medical centers. JAMA 278:234–240PubMedCrossRef
5.
Shapiro NI, Wolfe RE, Moore RB, Smith E, Burdick E, Bates DW (2003) Mortality in Emergency Department Sepsis (MEDS) score: a prospectively derived and validated clinical prediction rule. Crit Care Med 31:670–675PubMedCrossRef
6.
Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344:699–709PubMedCrossRef
7.
Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:1368–1377PubMedCrossRef
8.
Nguyen HB, Rivers EP, Havstad S, Knoblich B, Ressler JA, Muzzin AM, Tomlanovich MC (2000) Critical care in the emergency department: a physiologic assessment and outcome evaluation. Acad Emerg Med 7:1354–1361PubMedCrossRef
9.
Strehlow MC, Emond SD, Shapiro NI, Pelletier AJ, Camargo CA Jr (2006) National study of emergency department visits for sepsis, 1992 to 2001. Ann Emerg Med 48:326–331PubMedCrossRef
10.
Anwaruddin S, Askari AT, Topol EJ (2007) Redefining risk in acute coronary syndromes using molecular medicine. J Am Coll Cardiol 49:279–289PubMedCrossRef
11.
Bozza FA, Gomes RN, Japiassú AM, Soares M, Castro-Faria-Neto HC, Bozza PT, Bozza MT (2004) Macrophage migration inhibitory factor levels correlate with fatal outcome in sepsis. Shock 22:309–313PubMedCrossRef
12.
Casey LC, Balk RA, Bone RC (1993) Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 119:771–778PubMed
13.
Kellett J, Deane B (2006) The Simple Clinical Score predicts mortality for 30 days after admission to an acute medical unit. QJM 99:771–781PubMedCrossRef
14.
Shapiro N, Howell MD, Bates DW, Angus DC, Ngo L, Talmor D (2006) The association of sepsis syndrome and organ dysfunction with mortality in emergency department patients with suspected infection. Ann Emerg Med 48:583–590PubMedCrossRef
15.
Shapiro NI, Howell MD, Talmor D, Nathanson LA, Lisbon A, Wolfe RE, Weiss JW (2005) Serum lactate as a predictor of mortality in emergency department patients with infection. Ann Emerg Med 45:524–528PubMedCrossRef
16.
Chuang CC, Wang ST, Chen WC, Chen CC, Hor LI, Chuang AY (2007) Increases in serum macrophage migration inhibitory factor in patients with severe sepsis predict early mortality. Shock 27:503–506PubMedCrossRef
17.
Gaïni S, Koldkjaer OG, Pedersen C, Pedersen SS (2006) Procalcitonin, lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in community-acquired infections and sepsis: a prospective study. Crit Care 10:R53PubMedCrossRef
18.
Engel C, Brunkhorst FM, Bone HG, Brunkhorst R, Gerlach H, Grond S, Gruendling M, Huhle G, Jaschinski U, John S, Mayer K, Oppert M, Olthoff D, Quintel M, Ragaller M, Rossaint R, Stüber F, Weiler N, Welte T, Bogatsch H, Hartog C, Loeffler M, Reinhart K (2007) Epidemiology of sepsis in Germany: results from a national prospective multicenter study. Intensive Care Med 33:606–618PubMedCrossRef
19.
Le Gall JR, Lemeshow S, Saulnier F (1993) A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 270:2957–2963PubMedCrossRef
20.
Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, Reinhart CK, Suter PM, Thijs LG (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22:707–710PubMedCrossRef
21.
Weycker D, Akhras KS, Edelsberg J, Angus DC, Oster G (2003) Long-term mortality and medical care charges in patients with severe sepsis. Crit Care Med 31:2316–2323PubMedCrossRef
22.
Vincent JL (2004) Endpoints in sepsis trials: more than just 28-day mortality? Crit Care Med 32:S209–S213PubMedCrossRef
23.
Giamarellos-Bourboulis EJ, Tsaganos T, Spyridaki E, Mouktaroudi M, Plachouras D, Vaki I, Karagianni V, Antonopoulou A, Veloni V, Giamarellou H (2006) Early changes of CD4-positive lymphocytes and NK cells in patients with severe Gram-negative sepsis. Crit Care 10:R166PubMedCrossRef
24.
Gibot S, Kolopp-Sarda MN, Béné MC, Cravoisy A, Levy B, Faure GC, Bollaert PE (2004) Plasma level of a triggering receptor expressed on myeloid cells-1: its diagnostic accuracy in patients with suspected sepsis. Ann Intern Med 141:9–15PubMed
25.
Ostergaard C, Benfield T, Lundgren JD, Eugen-Olsen J (2004) Soluble urokinase receptor is elevated in cerebrospinal fluid from patients with purulent meningitis and is associated with fatal outcome. Scand J Infect Dis 36:14–19PubMedCrossRef
26.
Perch M, Kofoed P, Fischer TK, Có F, Rombo L, Aaby P, Eugen-Olsen J (2004) Serum levels of soluble urokinase plasminogen activator receptor is associated with parasitemia in children with acute Plasmodium falciparum malaria infection. Parasite Immunol 26:207–211PubMedCrossRef
27.
Sidenius N, Sier CF, Ullum H, Pedersen BK, Lepri AC, Blasi F, Eugen-Olsen J (2000) Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection. Blood 96:4091–4095PubMed
28.
Chuang CC, Hung CJ, Tsai MC, Yeh TM, Chuang YC (2004) High concentrations of circulating macrophage migration inhibitory factor in patients with severe blunt trauma: is serum macrophage migration inhibitory factor concentration a valuable prognostic factor? Crit Care Med 32:734–739PubMedCrossRef
29.
Rahman SH, Menon KV, Holmfield JH, McMahon MJ, Guillou JP (2007) Serum macrophage migration inhibitory factor is an early marker of pancreatic necrosis in acute pancreatitis. Ann Surg 245:282–289PubMedCrossRef
30.
Emonts M, Sweep FC, Grebenchtchikov N, Geurts-Moespot A, Knaup M, Chanson AL, Erard V, Renner P, Hermans PW, Hazelzet JA, Calandra T (2007) Association between high levels of blood macrophage migration inhibitory factor, inappropriate adrenal response, and early death in patients with severe sepsis. Clin Infect Dis 44:1321–1328PubMedCrossRef
31.
Kofoed K, Andersen O, Kronborg G, Tvede M, Petersen J, Eugen-Olsen J, Larsen K (2007) Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study. Crit Care 11:R38PubMedCrossRef
32.
33.
Kofoed K, Schneider UV, Scheel T, Andersen O, Eugen-Olsen J (2006) Development and validation of a multiplex add-on assay for sepsis biomarkers using xMAP technology. Clin Chem 52:1284–1293PubMedCrossRef
34.
35.
Xiong C, McKeel DW Jr, Miller JP, Morris JC (2004) Combining correlated diagnostic tests: application to neuropathologic diagnosis of Alzheimer’s disease. Med Decis Making 24:659–669PubMedCrossRef
36.
Hanley JA, McNeil BJ (1983) A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148:839–843PubMed
37.
Auriant I, Vinatier I, Thaler F, Tourneur M, Loirat P (1998) Simplified acute physiology score II for measuring severity of illness in intermediate care units. Crit Care Med 26:1368–1371PubMedCrossRef
38.
Beck DH, Smith GB, Pappachan JV, Millar B (2003) External validation of the SAPS II, APACHE II and APACHE III prognostic models in South England: a multicentre study. Intensive Care Med 29:249–256PubMed
39.
Castella X, Artigas A, Bion J, Kari A (1995) A comparison of severity of illness scoring systems for intensive care unit patients: results of a multicenter, multinational study. The European/North American Severity Study Group. Crit Care Med 23:1327–1335PubMedCrossRef
40.
Ferreira FL, Bota DP, Bross A, Mélot C, Vincent JL (2001) Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 286:1754–1758PubMedCrossRef
41.
Junger A, Engel J, Benson M, Böttger S, Grabow C, Hartmann B, Michel A, Röhrig R, Marquardt K, Hempelmann G (2002) Discriminative power on mortality of a modified Sequential Organ Failure Assessment score for complete automatic computation in an operative intensive care unit. Crit Care Med 30:338–342PubMedCrossRef
42.
Katsaragakis S, Papadimitropoulos K, Antonakis P, Strergiopoulos S, Konstadoulakis MM, Androulakis G (2000) Comparison of Acute Physiology and Chronic Health Evaluation II (APACHE II) and Simplified Acute Physiology Score II (SAPS II) scoring systems in a single Greek intensive care unit. Crit Care Med 28:426–432PubMedCrossRef
43.
Moreno R, Apolone G, Miranda DR (1998) Evaluation of the uniformity of fit of general outcome prediction models. Intensive Care Med 24:40–47PubMedCrossRef
44.
Nouira S, Belghith M, Elatrous S, Jaafoura M, Ellouzi M, Boujdaria R, Gahbiche M, Bouchoucha S, Abroug F (1998) Predictive value of severity scoring systems: comparison of four models in Tunisian adult intensive care units. Crit Care Med 26:852–859PubMedCrossRef
45.
Peres Bota D, Mélot C, Lopes Ferreira F, Nguyen Ba V, Vincent J-L (2002) The Multiple Organ Dysfunction Score (MODS) versus the Sequential Organ Failure Assessment (SOFA) score in outcome prediction. Intensive Care Med 28:1619–1624PubMedCrossRef
46.
Tan IK (1998) APACHE II and SAPS II are poorly calibrated in a Hong Kong intensive care unit. Ann Acad Med Singapore 27:318–322PubMed
47.
Ulvik A, Wentzel-Larsen T, Flaatten H (2007) Trauma patients in the intensive care unit: short- and long-term survival and predictors of 30-day mortality. Acta Anaesthesiol Scand 51:171–177PubMedCrossRef
48.
Shapiro NI, Howell MD, Talmor D, Donnino M, Ngo L, Bates DW (2007) Mortality in Emergency Department Sepsis (MEDS) score predicts 1-year mortality. Crit Care Med 35:192–198PubMedCrossRef
49.
Gando S, Nishihira J, Kobayashi S, Morimoto Y, Nanzaki S, Kemmotsu O (2001) Macrophage migration inhibitory factor is a critical mediator of systemic inflammatory response syndrome. Intensive Care Med 27:1187–1193PubMedCrossRef
50.
Lehmann LE, Novender U, Schroeder S, Pietsch T, von Spiegel T, Putensen C, Hoeft A, Stüber F (2001) Plasma levels of macrophage migration inhibitory factor are elevated in patients with severe sepsis. Intensive Care Med 27:1412–1415PubMedCrossRef
51.
Dahaba AA, Hagara B, Fall A, Rehak PH, List WF, Metzler H (2006) Procalcitonin for early prediction of survival outcome in postoperative critically ill patients with severe sepsis. Br J Anaesth 97:503–508PubMedCrossRef
52.
Heper Y, Akalin EH, Mistik R, Akgöz S, Töre O, Göral G, Oral B, Budak F, Helvaci S (2006) Evaluation of serum C-reactive protein, procalcitonin, tumor necrosis factor alpha, and interleukin-10 levels as diagnostic and prognostic parameters in patients with community-acquired sepsis, severe sepsis, and septic shock. Eur J Clin Microbiol Infect Dis 25:481–491PubMedCrossRef
53.
Oberholzer A, Souza SM, Tschoeke SK, Oberholzer C, Abouhamze A, Pribble JP, Moldawer LL (2005) Plasma cytokine measurements augment prognostic scores as indicators of outcome in patients with severe sepsis. Shock 23:488–493PubMed
54.
Jensen JU, Heslet L, Jensen TH, Espersen K, Steffensen P, Tvede M (2006) Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med 34:2596–2602PubMedCrossRef
55.
Bishara J, Hadari N, Shalita-Chesner M, Samra Z, Ofir O, Paul M, Peled N, Pitlik S, Molad Y (2007) Soluble triggering receptor expressed on myeloid cells-1 for distinguishing bacterial from aseptic meningitis in adults. Eur J Clin Microbiol Infect Dis 26:647–650PubMedCrossRef
56.
Muller B, Gencay MM, Gibot S, Stolz D, Hunziker L, Tamm M, Christ-Crain M (2007) Circulating levels of soluble triggering receptor expressed on myeloid cells (sTREM)-1 in community-acquired pneumonia. Crit Care Med 35:990–991PubMedCrossRef
57.
Tejera A, Santolaria F, Diez ML, Alemán-Valls MR, González-Reimers E, Martinez-Riera A, Milena-Abril A (2007) Prognosis of community acquired pneumonia (CAP): value of triggering receptor expressed on myeloid cells-1 (TREM-1) and other mediators of the inflammatory response. Cytokine 38:117–123PubMedCrossRef
58.
Fortin CF, Lesur O, Fulop T Jr (2007) Effects of aging on triggering receptor expressed on myeloid cells (TREM)-1-induced PMN functions. FEBS Lett 581:1173–1178PubMedCrossRef
59.
Mire-Sluis AR, Gaines-Das R, Thorpe R (1995) Immunoassays for detecting cytokines: what are they really measuring? J Immunol Methods 186:157–160PubMedCrossRef
60.
Eugen-Olsen J, Stausgaard A, Kahns L, Kyhse-Andersen J, Teversham K (2006) suPARnostic™, a novel and simple assay for monitoring HIV disease progression. In: Abstract and programme of the 16th International AIDS Conference, Toronto, Canada, August 2006, abstract no MoPE0141
Metadata
Title
Predicting mortality in patients with systemic inflammatory response syndrome: an evaluation of two prognostic models, two soluble receptors, and a macrophage migration inhibitory factor
Authors
K. Kofoed
J. Eugen-Olsen
J. Petersen
K. Larsen
O. Andersen
Publication date
01-05-2008
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 5/2008
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-007-0447-5

Other articles of this Issue 5/2008

European Journal of Clinical Microbiology & Infectious Diseases 5/2008 Go to the issue

Article

Fungal endophthalmitis in a tertiary care cancer center: a review of 23 cases

Erratum

SCCmec and spa types of methicillin-resistant Staphylococcus aureus strains in Israel. Detection of SCCmec type V

Brief Report

Repeated enzyme immunoassays have limited utility in diagnosing Clostridium difficile

Article

Recent findings on pertussis epidemiology in Turkey

Brief Report

Socks but no gloves

Concise Article

Quick and reliable galactomannan detection in crude minced lung specimens from haematological patients with suspected invasive fungal infection: results from a case series
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits